ANI Pharmaceuticals (NASDAQ: ANIP) dividends paid
ANI Pharmaceuticals paid $1.2m in dividends in fiscal 2025, 28.8% less than in fiscal 2024 ($1.6m). That was 1.5% of its net income for the year. It is the total cash paid according to its cash flow statement, not the dividend per share.
Dividends paid by fiscal year
| Fiscal year | Dividends paid | Change | Payout ratio |
|---|---|---|---|
| 2025 | $1.2m | −28.8% | 1.5% |
| 2024 | $1.6m | 0.0% | — |
| 2023 | $1.6m | 0.0% | 8.7% |
| 2022 | $1.6m | +755.3% | — |
| 2021 | $0.2m | — | — |
| 2020 | $0.0m | — | — |
| 2019 | $0.0m | — | 0.0% |
The figure for each fiscal year is the total cash paid in dividends according to the cash flow statement in the annual accounts. It is not the dividend per share and may include amounts paid to minority shareholders of subsidiaries. It covers closed fiscal years and is not a forecast. The change compares each fiscal year with the one before and is not shown when the amount paid is more than ten times the previous one. The payout ratio divides dividends paid by net income for the same fiscal year and is not calculated when net income was not positive. Figures are in millions of US dollars.
Questions about the dividends of ANI Pharmaceuticals
- How much did ANI Pharmaceuticals pay in dividends in fiscal 2025?
- ANI Pharmaceuticals paid $1.2m in dividends in fiscal 2025, according to its cash flow statement; in fiscal 2024 it paid $1.6m.
- What share of its profit did ANI Pharmaceuticals pay out?
- In fiscal 2025 dividends paid were 1.5% of its net income, which was $78.3m.
- In which year did ANI Pharmaceuticals pay the most in dividends?
- Of its last 7 fiscal years with the figure, fiscal 2024, with $1.6m paid in dividends.
- Where do the figures for ANI Pharmaceuticals come from?
- From the annual report (Form 10-K) that ANI Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ANI Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on ANI Pharmaceuticals: the ANI Pharmaceuticals page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.